HIV and HCV Serostatus and Knowledge Among Patients in Urban Versus Rural Methadone Maintenance Clinics in Kunming

The purpose of this study was to document the prevalence of Human Immunodeficiency Virus (HIV) and Hepatitis C Virus (HCV) among urban and rural methadone maintenance treatment (MMT) patients and to examine differences in knowledge of HIV and HCV among this population. We compared 147 MMT patients attending urban versus rural clinics in Kunming, Yunnan, China, concerning their serostatus and knowledge of HIV and HCV. The rates of HIV and HCV seropositive status were higher among rural patients. Both urban and rural patients showed limited HIV and HCV knowledge. Recent opioid injection and geographic area were strong predictors of HIV and HCV serostatus. The lack of knowledge of HIV and HCV among both urban and rural MMT patients suggests the need to strengthen current HIV and HCV education programs in MMT clinics. In addition, prevention programs should take into consideration geographic characteristics of the target population.

[1]  Min Zhao,et al.  Methadone maintenance treatment in China: perceived challenges from the perspectives of service providers and patients. , 2013, Journal of public health.

[2]  David P. Wilson,et al.  Risk factors associated with HIV/HCV infection among entrants in methadone maintenance treatment clinics in China: a systematic review and meta-analysis. , 2012, Drug and alcohol dependence.

[3]  David P. Wilson,et al.  HIV and HCV prevalence among entrants to methadone maintenance treatment clinics in China: a systematic review and meta-analysis , 2012, BMC Infectious Diseases.

[4]  Y. Hser,et al.  Hepatitis C among methadone maintenance treatment patients in Shanghai and Kunming, China. , 2012, Journal of public health.

[5]  J. Montaner,et al.  HIV knowledge and perceptions of risk in a young, urban, drug-using population. , 2011, Public health.

[6]  R. Detels,et al.  Multiple viral coinfections among HIV/AIDS patients in China. , 2011, Bioscience trends.

[7]  Yong-tang Zheng,et al.  Comparison of HIV-, HBV-, HCV- and Co-Infection Prevalence between Chinese and Burmese Intravenous Drug Users of the China-Myanmar Border Region , 2011, PloS one.

[8]  W. Guo,et al.  Estimating the number of people living with HIV/AIDS in China: 2003–09 , 2010, International journal of epidemiology.

[9]  Zunyou Wu,et al.  Scaling up the national methadone maintenance treatment program in China: achievements and challenges , 2010, International journal of epidemiology.

[10]  Y. Bao,et al.  Review of HIV and HCV infection among drug users in China , 2010, Current opinion in psychiatry.

[11]  X-L Wang,et al.  A model of expanding HIV/AIDS education in Chinese rural areas , 2010, International journal of STD & AIDS.

[12]  Lin Lu,et al.  The HIV Epidemic in Yunnan Province, China, 1989-2007 , 2010, Journal of acquired immune deficiency syndromes.

[13]  Y. Bao,et al.  Systematic review of HIV and HCV infection among drug users in China , 2009, International journal of STD & AIDS.

[14]  Changyong Feng,et al.  Predicting sexual risk behaviors among adolescent and young women using a prospective diary method. , 2008, Research in nursing & health.

[15]  Kevin Knight,et al.  Measuring Offender Attributes and Engagement in Treatment Using the Client Evaluation of Self and Treatment , 2007 .

[16]  D. D. Des Jarlais,et al.  Drug treatment program patients' hepatitis C virus (HCV) education needs and their use of available HCV education services , 2007, BMC Health Services Research.

[17]  Zunyou Wu,et al.  Rapid scale up of harm reduction in China. , 2007, The International journal on drug policy.

[18]  Yu Wang,et al.  Evolution of China's response to HIV/AIDS , 2007, The Lancet.

[19]  V. Chongsuvivatwong,et al.  Rural-urban differentials of premature mortality burden in south-west China , 2006, International journal for equity in health.

[20]  D. D. Jarlais,et al.  Hepatitis C Knowledge among Staff in U.S. Drug Treatment Programs , 2006, Journal of drug education.

[21]  S. Vermund,et al.  Risk of HIV/AIDS in China: subpopulations of special importance , 2005, Sexually Transmitted Infections.

[22]  S. Lai,et al.  Coinfection with HIV and hepatitis C virus among injection drug users in southern China. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[23]  H. Xing,et al.  Community-based survey of HCV and HIV coinfection in injection drug abusers in Sichuan Province of China. , 2004, World journal of gastroenterology.

[24]  Kerstin E. E. Schroder,et al.  Development and psychometric evaluation of the brief HIV Knowledge Questionnaire. , 2002, AIDS education and prevention : official publication of the International Society for AIDS Education.

[25]  Y. Takebe,et al.  High Prevalence of HIV‐1 and Hepatitis C Virus Coinfection Among Injection Drug Users in the Southeastern Region of Yunnan, China , 2002, Journal of acquired immune deficiency syndromes.

[26]  Jie Chen,et al.  Overland heroin trafficking routes and HIV-1 spread in south and south-east Asia , 2000, AIDS.

[27]  Blair T. Johnson,et al.  The HIV-Knowledge Questionnaire: Development and Evaluation of a Reliable, Valid, and Practical Self-Administered Questionnaire , 1997, AIDS and Behavior.

[28]  J. Watters,et al.  Reliability of Self-Reported HIV Risk Behaviors of Drug Users , 1995 .

[29]  J. Watters,et al.  Validity of self-reported drug use among injection drug users and crack cocaine users recruited through street outreach , 1994 .

[30]  N. Heather,et al.  The reliability and validity of a scale to measure HIV risk-taking behaviour among intravenous drug users. , 1991, AIDS.